MNTA
Momenta Pharmaceuticals, Inc.
MNTA
MNTA
Delisted
MNTA was delisted on the 30th of September, 2020.
237 hedge funds and large institutions have $4.11B invested in Momenta Pharmaceuticals, Inc. in 2020 Q2 according to their latest regulatory filings, with 58 funds opening new positions, 96 increasing their positions, 59 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
19% more funds holding
Funds holding: 199 → 237 (+38)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
237
Holding in Top 10
3
Calls
$5.26M
Puts
$1.92M
Top Buyers
| 1 | +$46.9M | |
| 2 | +$42.6M | |
| 3 | +$32.2M | |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
+$30.1M |
| 5 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
+$23.4M |
Top Sellers
| 1 | -$49.4M | |
| 2 | -$33.7M | |
| 3 | -$26.6M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$22.9M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$18.6M |